Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?
- PMID: 20094815
- DOI: 10.1007/s11605-009-1146-6
Reflux, Barrett's, and adenocarcinoma of the esophagus: can we disrupt the pathway?
Similar articles
-
Importance of a multidisciplinary approach for the treatment of Barrett's esophagus.Updates Surg. 2011 Mar;63(1):5-9. doi: 10.1007/s13304-011-0049-8. Epub 2011 Feb 10. Updates Surg. 2011. PMID: 21308492 Review.
-
Pathophysiology and treatment of Barrett's esophagus.World J Gastroenterol. 2010 Aug 14;16(30):3762-72. doi: 10.3748/wjg.v16.i30.3762. World J Gastroenterol. 2010. PMID: 20698038 Free PMC article. Review.
-
Molecular targets for treatment of Barrett's esophagus.Dis Esophagus. 2005;18(2):75-86. doi: 10.1111/j.1442-2050.2005.00465.x. Dis Esophagus. 2005. PMID: 16053481 Review.
-
Barrett's esophagus and risk of esophageal adenocarcinoma.Semin Gastrointest Dis. 2003 Jul;14(3):128-35. Semin Gastrointest Dis. 2003. PMID: 14653412 Review.
-
Changing role of in vivo models in columnar-lined lower esophagus.Dis Esophagus. 2002;15(4):271-7. doi: 10.1046/j.1442-2050.2002.00268.x. Dis Esophagus. 2002. PMID: 12472470 Review.
Cited by
-
Review on novel concepts of columnar lined esophagus.Wien Klin Wochenschr. 2013 Oct;125(19-20):577-90. doi: 10.1007/s00508-013-0418-z. Epub 2013 Sep 6. Wien Klin Wochenschr. 2013. PMID: 24061694 Review.
-
Optimizing Patient Selection and Outcomes for Surgical Treatment of GERD and Achalasia.Curr Treat Options Gastroenterol. 2015 Mar;13(1):1-15. doi: 10.1007/s11938-014-0035-6. Curr Treat Options Gastroenterol. 2015. PMID: 25595928
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical